Robert A. Lahti

4.1k total citations · 1 hit paper
87 papers, 3.5k citations indexed

About

Robert A. Lahti is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Robert A. Lahti has authored 87 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 42 papers in Cellular and Molecular Neuroscience and 18 papers in Organic Chemistry. Recurrent topics in Robert A. Lahti's work include Receptor Mechanisms and Signaling (33 papers), Neuropeptides and Animal Physiology (21 papers) and Neurotransmitter Receptor Influence on Behavior (20 papers). Robert A. Lahti is often cited by papers focused on Receptor Mechanisms and Signaling (33 papers), Neuropeptides and Animal Physiology (21 papers) and Neurotransmitter Receptor Influence on Behavior (20 papers). Robert A. Lahti collaborates with scholars based in United States, Sweden and Netherlands. Robert A. Lahti's co-authors include Philip F. VonVoigtlander, James H. Ludens, Craig L. Barsuhn, P. F. VON VOIGTLANDER, Mary M. Mickelson, John M. McCall, Carol A. Tamminga, R. James Collins, Rosalinda C. Roberts and Montford F. Piercey and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Medicinal Chemistry.

In The Last Decade

Robert A. Lahti

85 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

1983 716 citations Philip F. VonVoigtlander, Robert A. Lahti et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Lahti United States	28	2.4k	2.0k	614	304	278	87	3.5k
G. Engel Germany	23	2.2k 0.9×	2.0k 1.0×	651 1.1×	244 0.8×	218 0.8×	55	3.6k
Bradley V. Clineschmidt United States	32	2.1k 0.9×	1.8k 0.9×	879 1.4×	311 1.0×	213 0.8×	86	3.8k
Ewan J. Mylecharane Australia	18	2.5k 1.1×	2.0k 1.0×	866 1.4×	290 1.0×	503 1.8×	39	4.2k
Ann G. Hayes United Kingdom	30	1.6k 0.7×	1.2k 0.6×	804 1.3×	198 0.7×	170 0.6×	58	2.5k
W. Kehr Germany	29	2.5k 1.0×	1.3k 0.7×	453 0.7×	326 1.1×	229 0.8×	68	3.4k
Hans O. Kalkman Switzerland	30	1.7k 0.7×	1.8k 0.9×	592 1.0×	222 0.7×	530 1.9×	68	3.6k
Bevyn Jarrott Australia	38	2.0k 0.8×	1.9k 0.9×	756 1.2×	133 0.4×	186 0.7×	230	4.8k
Michael G. Palfreyman France	32	1.8k 0.7×	1.3k 0.7×	291 0.5×	329 1.1×	454 1.6×	99	3.3k
Milt Titeler United States	33	2.6k 1.1×	1.7k 0.9×	230 0.4×	526 1.7×	198 0.7×	70	3.6k
Bertil Waldeck Sweden	36	2.1k 0.9×	1.8k 0.9×	1.2k 2.0×	249 0.8×	201 0.7×	130	4.7k

Countries citing papers authored by Robert A. Lahti

Since Specialization

Citations

This map shows the geographic impact of Robert A. Lahti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Lahti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Lahti more than expected).

Fields of papers citing papers by Robert A. Lahti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Lahti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Lahti. The network helps show where Robert A. Lahti may publish in the future.

Co-authorship network of co-authors of Robert A. Lahti

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Lahti. A scholar is included among the top collaborators of Robert A. Lahti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Lahti. Robert A. Lahti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lahti, Robert A., Carol A. Tamminga, & Arvid Carlsson. (2007). Stimulating and inhibitory effects of the dopamine “stabilizer” (−)-OSU6162 on dopamine D2 receptor function in vitro. Journal of Neural Transmission. 114(9). 1143–1146. 20 indexed citations

Lahti, Robert A. & Carol A. Tamminga. (1999). Effect Of amphetamine, α-Methyl-P-tyrosine (α-MPT) and antipsychotic agents on dopamine D2-type receptor occupancy in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 23(7). 1277–1283. 7 indexed citations

Lahti, Adrienne C., et al.. (1998). Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia. Biological Psychiatry. 43(1). 2–11. 85 indexed citations

Lahti, Robert A., et al.. (1998). [. Journal of Neural Transmission. 105(4). 507–507. 27 indexed citations

Lahti, Robert A., Rosalinda C. Roberts, Renee Primus, et al.. (1998). Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study. Molecular Psychiatry. 3(6). 528–533. 69 indexed citations

Lahti, Robert A., et al.. (1996). D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects. Neuroreport. 7(12). 1945–1948. 31 indexed citations

Lahti, Robert A., et al.. (1996). Affinities and intrinsic activities of dopamine receptor agonists for the hD21 and hD4.4 receptors. European Journal of Pharmacology. 301(1-3). R11–R13. 15 indexed citations

Piercey, Montford F., A. H. Tang, Robert A. Lahti, et al.. (1994). Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.. Journal of Pharmacology and Experimental Therapeutics. 268(3). 1304–1310. 7 indexed citations

Haadsma‐Svensson, Susanne R., Robert A. Lahti, Robert B. McCall, et al.. (1993). Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives. Journal of Medicinal Chemistry. 36(8). 1053–1068. 11 indexed citations

10.

Haadsma‐Svensson, Susanne R., Robert A. Lahti, Robert B. McCall, et al.. (1993). Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives. Journal of Medicinal Chemistry. 36(8). 1069–1083. 17 indexed citations

11.

Jackson, Twila A., et al.. (1992). Antagonism of kainic acid lesions in the mouse hippocampus by U-54494A and U-50488H. Life Sciences. 51(14). 1135–1143. 6 indexed citations

12.

Ennis, Michael D., et al.. (1992). Novel indolodioxanes with antihypertensive effects: potent ligands for the 5-HT1A receptor. Journal of Medicinal Chemistry. 35(16). 3058–3066. 11 indexed citations

13.

Lahti, Robert A., et al.. (1992). INTRINSIC ACTIVITY OF DA AGONISTS. Clinical Neuropharmacology. 15. 182A–183A. 5 indexed citations

14.

Hall, Edward D., J. Mark Braughler, Patricia A. Yonkers, et al.. (1991). U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia.. Journal of Pharmacology and Experimental Therapeutics. 258(2). 688–694. 131 indexed citations

15.

Lahti, Robert A., et al.. (1991). Pre- and postsynaptic dopaminergic activities of U-86170F. Naunyn-Schmiedeberg s Archives of Pharmacology. 344(5). 509–13. 6 indexed citations

16.

Lahti, Robert A., et al.. (1989). Comparative neuroanatomical distribution of the κ and μ opioid receptors in guinea pig brain sections. European Journal of Pharmacology. 166(3). 563–566. 24 indexed citations

17.

Barton, Anne, et al.. (1989). Autoradiographic Identification of Prolactin Binding Sites in Rat Median Eminence. Neuroendocrinology. 49(6). 649–653. 36 indexed citations

18.

Braughler, J. Mark, R L Chase, Patricia A. Yonkers, et al.. (1988). A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates adrenocorticotropin secretion and blocks arachidonic acid release from mouse pituitary tumor (AtT-20) cells.. Journal of Pharmacology and Experimental Therapeutics. 244(2). 423–427. 120 indexed citations

19.

Cheney, B. Vernon, et al.. (1982). An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model.. Molecular Pharmacology. 22(2). 349–359. 12 indexed citations

20.

Johnson, George, Robert A. Lahti, Thomas Lemke, & Richard V. Heinzelman. (1969). Effect of α-methyl-5-hydroxytryptophan ethyl ester upon tissue norepinephrine levels in rats and mice. Biochemical Pharmacology. 18(7). 1593–1600. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact